MedPath

Imiglitazar

Generic Name
Imiglitazar
Drug Type
Small Molecule
Chemical Formula
C28H26N2O5
CAS Number
250601-04-8
Unique Ingredient Identifier
7244710F59

Overview

Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.

Background

Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath